Inactive Instrument

Abcam plc London S.E.

Equities

ABC

GB00B6774699

Pharmaceuticals

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Global markets live: Mastercard, Diageo, Nvidia, Airbnb, Exxon Mobil... Our Logo
Job losses delight investors Our Logo
Danaher Closes Acquisition of Abcam MT
Danaher completes $5.7 billion acquisition of Abcam RE
Abcam plc(NasdaqGS:ABCM) dropped from NASDAQ Composite Index CI
Abcam plc(NasdaqGS:ABCM) dropped from NASDAQ Biotechnology Index CI
Abcam plc(NasdaqGS:ABCM) dropped from S&P Global BMI Index CI
Danaher Corporation completed the acquisition of Abcam plc. CI
Abcam's Acquisition by Danaher Approved by UK Court MT
Abcam Says All Necessary Clearances for Acquisition by Danaher Obtained; Deal Set to be Completed on Dec. 6 MT
All good things must come to an end Our Logo
Abcam Shareholders Approve Danaher's Acquisition Offer MT
Abcam shareholders approve $5.7 billion Danaher deal RE
Jonathan Milner Suspends his Vote Against Campaign CI
RBC Trims Price Target on Abcam to $24 From $25, Keeps Sector Perform Rating MT
Jonathan Milner Issues Statement Responding to the Glass Lewis Report CI
Jonathan Milner Continues Opposition to Danaher Corporation Acquisition CI
Institutional Shareholder Services Recommends Shareholders Vote for Danaher Corporation?s Proposed Acquisition of Abcam plc CI
Jonathan Milner Releases Presentation to Abcam plc Shareholders CI
Jonathan Milner issues Open Letter to shareholders of Abcam plc CI
Abcam Sends Letter Seeking Shareholders' Approval of Danaher's Takeover Offer MT
Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher CI
Jonathan Milner issues Open Letter to Shareholders of Abcam plc CI
Abcam founder says he will vote against $5.7 billion Danaher deal RE
Abcam founder Jonathan Milner opposes Danaher deal RE
Chart Abcam plc
More charts
Abcam plc is a global life science company. The Company serves customers at the forefront of life science research through the identification, development, and distribution of biological reagents. Its products are used by researchers around the world to study biological pathways critical for scientific research, diagnostics, and drug discovery. It offers a selection of products in its catalogue to support research on proteins in biological pathways. Its principal catalogue product lines include primary and secondary antibodies, conjugated antibodies and conjugation kits, and singleplex immunoassays. It offers a range of peptides and proteins, which include cytokines, growth factors, and enzymes. It offers a range of knockout cell lines and lysates, which are used for its in-house validation needs and are also made available to its customers for their own research. It offers a variety of other products, including cellular activity kits, biochemicals and cell signaling pathway tools.
More about the company